Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texts and home visits aim to stop repeat STIs in young women

NCT ID NCT03828994

Prevention Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a program combining daily text reminders, nurse home visits, and field-based treatment can help young women (ages 13-25) avoid repeat sexually transmitted infections after being treated for pelvic inflammatory disease (PID). The 150 participants in Baltimore will receive extra support for 30 days. Researchers hope this approach will improve treatment adherence and reduce risky sexual behavior.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
text messaging and community health nurse visits
What this could lead to
If it works, this could offer a cost-effective way to reduce repeat infections and improve vaginal health in young women after PID.
What could go wrong
This is a small, early-stage behavioral study, not a drug trial. Results may not apply to other cities or populations, and adherence to the program may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2019

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 25 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Mild-moderate PID * Outpatient treatment disposition * Permanently reside in the Baltimore Metropolitan area * Willing to sign informed consent \& be randomized Exclusion Criteria: * Pregnant * Concurrent diagnosis of Sexual Assault * Unable to communicate/complete study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pelvic inflammatory disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pelvic inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pelvic inflammatory disease

Contacts and locations

Locations

  • Johns Hopkins School of Medicine

    Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.